Orbis Allan Gray’s Bristol-Myers Squibb BMY Stock Holding History

Orbis Allan Gray’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,608	Closed	-$201K	–	75
2022 Q2	$201K	Hold	2,608	–	–	﹤0.01%	72
2022 Q1	$190K	Buy	+2,608	New	+$175K	﹤0.01%	72
2020 Q2	–	Sell	-2,608	Closed	-$145K	–	63
2020 Q1	$145K	Sell	2,608 -5,479,261	-100%	-$335M	﹤0.01%	62
2019 Q4	$352M	Buy	+5,481,869	New	+$314M	2.46%	13
2019 Q2	–	Sell	-656,994	Closed	-$31.3M	–	58
2019 Q1	$31.3M	Sell	656,994 -3,458,095	-84%	-$172M	0.21%	33
2018 Q4	$214M	Buy	4,115,089 +998,296	+32%	+$53.6M	1.54%	16
2018 Q3	$193M	Buy	3,116,793 +158,735	+5%	+$9.42M	1.11%	23
2018 Q2	$164M	Sell	2,958,058 -4,585,538	-61%	-$248M	0.91%	24
2018 Q1	$477M	Buy	7,543,596 +641,926	+9%	+$41.3M	2.73%	15
2017 Q4	$423M	Buy	6,901,670 +1,635,666	+31%	+$102M	2.48%	16
2017 Q3	$336M	Buy	+5,266,004	New	+$307M	2.07%	19

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Orbis Allan Gray's BMY Position: Q3 2022 in Review

Orbis Allan Gray sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 2,608 shares — an estimated $201K sold.

Orbis Allan Gray first reported a position in BMY in Q3 2017 and held it in 11 quarters. The position peaked at $477M in Q1 2018. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

Orbis Allan Gray reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
Orbis Allan Gray sold 2,608 Bristol-Myers Squibb shares in Q3 2022, an estimated $201K.
Orbis Allan Gray first reported a position in Bristol-Myers Squibb in Q3 2017 and held it in 11 quarters.
Orbis Allan Gray's Bristol-Myers Squibb position peaked at $477M in Q1 2018.
2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Orbis Allan Gray's 13F filing for Q3 2022, filed 14 Nov 2022.